Sudeep Pharma Limited has intimated the National Stock Exchange of India Limited and BSE Limited about an upcoming board meeting scheduled for Tuesday, 4th August 2026.
The primary agenda for the board meeting is to consider, approve, and take on record the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended 30th June 2026. The board will also address other business items.
Pursuant to the Company's "Code of Internal Procedure and Conduct of Regulating, Monitoring and Reporting of Trading in Securities by Insiders" and SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window has been closed for all persons covered under the Code. The closure period is from Wednesday, 1st July 2026 until Thursday, 6th August 2026 (both days inclusive), which represents 48 hours after the declaration of the unaudited financial results.
This disclosure is made under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The communication was digitally signed by Dimple Mehta, Company Secretary & Compliance Officer (Membership No.: F13184), on behalf of Sudeep Pharma Limited.
Company CIN: L24231GJ1989PLC013141
Corporate Office: 601, 602, 6th Floor, Sears Towers-2, Gotri-Sevasi Road, Sevasi, Vadodara-390021, Gujarat, India